SPOTLIGHT -
Implications of Ozanimod Discontinuation Data for MS Care
Dr Brownlee shares his advice and recommendations from national MS society on providing cognitive care for patients suffering from MS.
Relapse Following Discontinuation of Ozanimod
A multiple sclerosis expert, Dr Brownlee shares study design and clinical data on relapse following discontinuation of ozanimod in patients with multiple sclerosis.
Treatment Discontinuation in Multiple Sclerosis
Dr Wallace Brownlee discusses reasons of and clinical impact of treatment discontinuation in multiple sclerosis.
The Future of Treating Multiple Sclerosis
Decision-Making Process for Treating Multiple Sclerosis
Switching Therapies in Multiple Sclerosis
Role of Ozanimod in Multiple Sclerosis
Role of Diroximel Fumarate in Multiple Sclerosis
Role of Ocrelizumab in Europe for Multiple Sclerosis
Ocrelizumab for the Treatment of Multiple Sclerosis
Role of Siponimod in Multiple Sclerosis
Treating With Cladribine in Multiple Sclerosis
Clinical Trials for Cladribine in Multiple Sclerosis
The Use of Glatiramer Acetate in Multiple Sclerosis
The Use of Interferon in Multiple Sclerosis
First-Line Therapies for Relapsing Multiple Sclerosis
Clinically Isolated Syndrome Versus Multiple Sclerosis
MOG-IgG in Multiple Sclerosis
Differential Diagnosis of Multiple Sclerosis
Diagnosis of Multiple Sclerosis: The McDonald Criteria
